You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《半日總結》恆指升39點 匯控造好 藥股及教育股受壓
美股道指收市反覆跌66點或0.2%,道指期貨亞洲早市靠穩。港股早市反覆。恆指高開99點,早段升243點一度高見24,487點,其後曾倒跌21點一度低見24,221點,半日升39或0.16%,報24,283點;國指升13點或0.16%,報8,517點;恆生科技指數升40點或0.74%,報5,593點。大市半日成交總額697.11億元,滬、深港通南下交易半日分別淨流入13.08億及15.36億元人民幣。 恆騰(00136.HK)向騰訊(00700.HK)等溢價逾9%配股淨籌3億元,恆騰昇6.1%報2.43元,騰訊升0.7%報470元。其他科技股方面,阿裏巴巴(09988.HK)跌0.1%報116.7元,美團(03690.HK)及小米(01810.HK)各跌0.6%及0.2%,京東(09618.HK)及百度(09888.HK)各升1.3%及1.9%,網易(09999.HK)反彈3.1%報154.7元。快手(01024.HK)及雲音樂(09899.HK)各升5.3%及5.5%。 國務院總理李克強指不搞大水漫灌,中銀保監指嚴防銀保資金被用於盲目加槓桿,內房股個別發展,恆大(03333.HK)、中海外(00688.HK)、碧桂園(02007.HK)及華潤置地(01109.HK)各升1.1%至1.7%。萬科(02202.HK)跌1.5%。世茂(00813.HK)擬聘德勤爲財務顧問,稱屬正常程序,股價跌0.2%報6.08元。 市場關注內地啓動藥品集中帶量採購工作,醫藥股受壓,信達生物(01801.HK)跌7.6%,藥明康德(02359.HK)及中國中藥(00570.HK)各跌6.8%及6.4%,藥明生物(02269.HK)跌5.1%,國藥(01099.HK)亦跌3.9%。 內需股個別發展,維達(03331.HK)去年純利跌13%,末期息增至40仙,早市股價升4.1%報20.75元。百威亞太(01876.HK)升3%。中國旺旺(00151.HK)、潤啤(00291.HK)及呷哺呷哺(00520.HK)各跌2.8%至3.4%,蒙牛(02319.HK)及九毛九(09922.HK)各跌2.2%。 多隻教育股急跌,宇華(06169.HK)及中教(00839.HK)各挫11.6%及25.3%,希望教育(01765.HK)及新高教(02001.HK)各跌逾9%。 國際銀行股反彈,匯控(00005.HK)升2.8%報53.8元,渣打(02888.HK)升4.1%報54.25元。其他藍籌方面,港交所(00388.HK)跌1.2%報462元。美銀證券降申洲(02313.HK)盈測反映人幣升值等不利因素,申洲跌6.7%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account